These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 24712424)

  • 21. Evidence supporting an altered immune response in ASD.
    Mead J; Ashwood P
    Immunol Lett; 2015 Jan; 163(1):49-55. PubMed ID: 25448709
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brain region-specific changes in oxidative stress and neurotrophin levels in autism spectrum disorders (ASD).
    Sajdel-Sulkowska EM; Xu M; McGinnis W; Koibuchi N
    Cerebellum; 2011 Mar; 10(1):43-8. PubMed ID: 20967576
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decoding the contribution of dopaminergic genes and pathways to autism spectrum disorder (ASD).
    Nguyen M; Roth A; Kyzar EJ; Poudel MK; Wong K; Stewart AM; Kalueff AV
    Neurochem Int; 2014 Jan; 66():15-26. PubMed ID: 24412511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cell adhesion molecules and their involvement in autism spectrum disorder.
    Ye H; Liu J; Wu JY
    Neurosignals; 2010; 18(2):62-71. PubMed ID: 21212702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pten haploinsufficient mice show broad brain overgrowth but selective impairments in autism-relevant behavioral tests.
    Clipperton-Allen AE; Page DT
    Hum Mol Genet; 2014 Jul; 23(13):3490-505. PubMed ID: 24497577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PTEN signaling in autism spectrum disorders.
    Zhou J; Parada LF
    Curr Opin Neurobiol; 2012 Oct; 22(5):873-9. PubMed ID: 22664040
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential cytokine biomarkers in autism spectrum disorders.
    Rose D; Ashwood P
    Biomark Med; 2014; 8(9):1171-81. PubMed ID: 25402586
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Maternal Anti-Fetal Brain IgG Autoantibodies and Autism Spectrum Disorder: Current Knowledge and its Implications for Potential Therapeutics.
    Fox-Edmiston E; Van de Water J
    CNS Drugs; 2015 Sep; 29(9):715-24. PubMed ID: 26369920
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autism spectrum disorder: an omics perspective.
    Woods AG; Wormwood KL; Wetie AG; Aslebagh R; Crimmins BS; Holsen TM; Darie CC
    Proteomics Clin Appl; 2015 Feb; 9(1-2):159-68. PubMed ID: 25311756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Relationship between vitamin D and autism spectrum disorder].
    Duan XY; Jia FY; Jiang HY
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Aug; 15(8):698-702. PubMed ID: 23965890
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Maternal autoantibodies are associated with abnormal brain enlargement in a subgroup of children with autism spectrum disorder.
    Nordahl CW; Braunschweig D; Iosif AM; Lee A; Rogers S; Ashwood P; Amaral DG; Van de Water J
    Brain Behav Immun; 2013 May; 30():61-5. PubMed ID: 23395715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The immune response in autism: a new frontier for autism research.
    Ashwood P; Wills S; Van de Water J
    J Leukoc Biol; 2006 Jul; 80(1):1-15. PubMed ID: 16698940
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autism-specific maternal autoantibodies recognize critical proteins in developing brain.
    Braunschweig D; Krakowiak P; Duncanson P; Boyce R; Hansen RL; Ashwood P; Hertz-Picciotto I; Pessah IN; Van de Water J
    Transl Psychiatry; 2013 Jul; 3(7):e277. PubMed ID: 23838888
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Are caesarean sections, induced labor and oxytocin regulation linked to Autism Spectrum Disorders?
    Gialloreti LE; Benvenuto A; Benassi F; Curatolo P
    Med Hypotheses; 2014 Jun; 82(6):713-8. PubMed ID: 24685110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Search for Blood Biomarkers for Autism: Peptoids.
    Zaman S; Yazdani U; Deng Y; Li W; Gadad BS; Hynan L; Karp D; Roatch N; Schutte C; Nathan Marti C; Hewitson L; German DC
    Sci Rep; 2016 Jan; 6():19164. PubMed ID: 26764136
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intestinal inflammation in a murine model of autism spectrum disorders.
    de Theije CG; Koelink PJ; Korte-Bouws GA; Lopes da Silva S; Korte SM; Olivier B; Garssen J; Kraneveld AD
    Brain Behav Immun; 2014 Mar; 37():240-7. PubMed ID: 24321212
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 1H-magnetic resonance spectroscopy markers of cognitive and language ability in clinical subtypes of autism spectrum disorders.
    Gabis L; Wei Huang ; Azizian A; DeVincent C; Tudorica A; Kesner-Baruch Y; Roche P; Pomeroy J
    J Child Neurol; 2008 Jul; 23(7):766-74. PubMed ID: 18487520
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neural targets in the study and treatment of social cognition in autism spectrum disorder.
    Vahabzadeh A; Landino SM; Finger BC; Carlezon WA; McDougle CJ
    Handb Exp Pharmacol; 2015; 228():309-34. PubMed ID: 25977088
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The neurobiology of lipid metabolism in autism spectrum disorders.
    Tamiji J; Crawford DA
    Neurosignals; 2010; 18(2):98-112. PubMed ID: 21346377
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Possible role of brain-derived neurotrophic factor (BDNF) in autism spectrum disorder: current status.
    Halepoto DM; Bashir S; A L-Ayadhi L
    J Coll Physicians Surg Pak; 2014 Apr; 24(4):274-8. PubMed ID: 24709243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.